Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Metastatic Colorectal Cancer (CRC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Clinical Study Site, Mobile, Alabama, United States

  • Clinical Study Site, Tuscaloosa, Alabama, United States

  • Clinical Study Site, Goodyear, Arizona, United States

  • Clinical Study Site, Beverly Hills, California, United States

  • Clinical Study Site, Beverly Hills, California, United States

  • Clinical Study Site, Cerritos, California, United States

  • Clinical Study Site, Corona, California, United States

  • Clinical Study Site, Duarte, California, United States

  • Clinical Study Site, Fountain Valley, California, United States

  • Clinical Study Site, Huntington Beach, California, United States

  • Clinical Study Site, Irvine, California, United States

  • Clinical Study Site, Irvine, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Murrieta, California, United States

  • Clinical Study Site, Orange, California, United States

  • Clinical Study Site, Pasadena, California, United States

  • Clinical Study Site, Torrance, California, United States

  • Clinical Study Site, Upland, California, United States

  • Clinical Study Site, West Hollywood, California, United States

  • Clinical Study Site, Hartford, Connecticut, United States

  • Clinical Study Site, New Haven, Connecticut, United States

  • Clinical Study Site, Norwich, Connecticut, United States

  • Clinical Study Site, Newark, Delaware, United States

  • Clinical Study Site, Hialeah, Florida, United States

  • Clinical Study Site, Miami, Florida, United States

  • Clinical Study Site, Orlando, Florida, United States

  • Clinical Study Site, Plantation, Florida, United States

  • Clinical Study Site, Port Saint Lucie, Florida, United States

  • Clinical Study Site, St. Petersburg, Florida, United States

  • Clinical Study Site, Tamarac, Florida, United States

  • Clinical Study Site, Atlanta, Georgia, United States

  • Clinical Study Site, Atlanta, Georgia, United States

  • Clinical Study Site, Newnan, Georgia, United States

  • Clinical Study Site, Chicago, Illinois, United States

  • Clinical Study Site, Elmhurst, Illinois, United States

  • Clinical Study Site, O'Fallon, Illinois, United States

  • Clinical Study Site, Fort Wayne, Indiana, United States

  • Clinical Study Site, Indianapolis, Indiana, United States

  • Clinical Study Site, Westwood, Kansas, United States

  • Clinical Study Site, Edgewood, Kentucky, United States

  • Clinical Study Site, New Orleans, Louisiana, United States

  • Clinical Study Site, Baltimore, Maryland, United States

  • Clinical Study Site, Detroit, Michigan, United States

  • Clinical Study Site, Saint Louis Park, Minnesota, United States

  • Clinical Study Site, Springfield, Missouri, United States

  • Clinical Study Site, Billings, Montana, United States

  • Clinical Study Site, Lincoln, Nebraska, United States

  • Clinical Study Site, Lebanon, New Hampshire, United States

  • Clinical Study Site, New Brunswick, New Jersey, United States

  • Clinical Study Site, Mineola, New York, United States

  • Clinical Study Site, New York, New York, United States

  • Clinical Study Site, Rochester, New York, United States

  • Clinical Study Site, Syracuse, New York, United States

  • Clinical Study Site, The Bronx, New York, United States

  • Clinical Study Site, White Plains, New York, United States

  • Clinical Study Site, Akron, Ohio, United States

  • Clinical Study Site, Canton, Ohio, United States

  • Clinical Study Site, Cincinnati, Ohio, United States

  • Clinical Study Site, Cincinnati, Ohio, United States

  • Clinical Study Site, Cleveland, Ohio, United States

  • Clinical Study Site, Cleveland, Ohio, United States

  • Clinical Study Site, Mayfield Heights, Ohio, United States

  • Clinical Study Site, Oklahoma City, Oklahoma, United States

  • Clinical Study Site, Lebanon, Pennsylvania, United States

  • Clinical Study Site, Philadelphia, Pennsylvania, United States

  • Clinical Study Site, Philadelphia, Pennsylvania, United States

  • Clinical Study Site, Pittsburgh, Pennsylvania, United States

  • Clinical Study Site, Providence, Rhode Island, United States

  • Clinical Study Site, Greenville, South Carolina, United States

  • Clinical Study Site, Hermitage, Tennessee, United States

  • Clinical Study Site, Dallas, Texas, United States

  • Clinical Study Site, Dallas, Texas, United States

  • Clinical Study Site, Fort Worth, Texas, United States

  • Clinical Study Site, Tyler, Texas, United States

  • Clinical Study Site, Salt Lake City, Utah, United States

  • Clinical Study Site, Charlottesville, Virginia, United States

  • Clinical Study Site, Fairfax, Virginia, United States

  • Clinical Study Site, Spokane, Washington, United States

  • Clinical Study Site, Tacoma, Washington, United States

  • Clinical Study Site, Charleston, West Virginia, United States

  • Clinical Study Site, Madison, Wisconsin, United States

  • Clinical Study Site, Brussels, Belgium

  • Clinical Study Site, Ghent, Belgium

  • Clinical Study Site, Haine-Saint-Paul, Belgium

  • Clinical Study Site, Kortrijk, Belgium

  • Clinical Study Site, Toronto, Ontario, Canada

  • Clinical Study Site, Montreal, Quebec, Canada

  • Clinical Study Site, Regina, Saskatchewan, Canada

  • Clinical Study Site, Hradec Králové, Czechia

  • Clinical Study Site, Prague, Czechia

  • Clinical Study Site, Lyon, France

  • Clinical Study Site, Montpellier, France

  • Clinical Study Site, Nantes, France

  • Clinical Study Site, Paris, France

  • Clinical Study Site, Paris, France

  • Clinical Study Site, Pierre-Bénite, France

  • Clinical Study Site, Poitiers, France

  • Clinical Study Site, Strasbourg, France

  • Clinical Study Site, Bonn, Germany

  • Clinical Study Site, Hamburg, Germany

  • Clinical Study Site, Hamburg, Germany

  • Clinical Study Site, Meldola, Italy

  • Clinical Study Site, Osaka, Ontario, Japan

  • Clinical Study Site, Aichi, Japan

  • Clinical Study Site, Chiba, Japan

  • Clinical Study Site, Ehime, Japan

  • Clinical Study Site, Fukuoka, Japan

  • Clinical Study Site, Gifu, Japan

  • Clinical Study Site, Hiroshima, Japan

  • Clinical Study Site, Hokkaido, Japan

  • Clinical Study Site, Kawasaki, Japan

  • Clinical Study Site, Osaka, Japan

  • Clinical Study Site, Saitama, Japan

  • Clinical Study Site, Sendai, Japan

  • Clinical Study Site, Shizuoka, Japan

  • Clinical Study Site, Tokyo, Japan

  • Clinical Study Site, Tokyo, Japan

  • Clinical Study Site, Toyama, Japan

  • Clinical Study Site, Yokohama, Japan

  • Clinical Study Site, Rzeszów, Podkarpackie Voivodeship, Poland

  • Clinical Study Site, Warsaw, Poland

  • Clinical Study Site, Rio Piedras, Puerto Rico

  • Clinical Study Site, A Coruña, Spain

  • Clinical Study Site, Barcelona, Spain

  • Clinical Study Site, Barcelona, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Palma de Mallorca, Spain

  • Clinical Study Site, Santander, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Canterbury, England, United Kingdom

  • Clinical Study Site, London, England, United Kingdom

  • Clinical Study Site, Aberdeen, Scotland, United Kingdom

  • Clinical Study Site, Edinburgh, United Kingdom

  • Clinical Study Site, Manchester, United Kingdom